ASX-listed cannabis companies are racing to get low-dose medicinal pot products onto shelves, with hopes they will be available through pharmacies by the end of next…
The rollout of New York’s new cannabis policies has new life after the state legislature confirmed appointments to oversee the regulatory process last week, but the…
As the German federal election fast approaches, with the governing parties in trouble, the cannabis question has become one of the hot topics during the campaign…
In a 69-30 vote, the Senate overwhelmingly approved the bipartisan $1 trillion infrastructure bill on Tuesday, which seeks to improve, among other things, the country’s roads, bridges, pipes,…
For the first time in the Olympics 125-year modern history, elite athletes are being open about their use of cannabis products to prepare them for the…
The Swiss government is planning the launch of its eagerly awaited pilot scheme, designed to assess the implications of recreational cannabis legalisation. The scheme was approved…
GREEK businesses are preparing for amendments to the Mediterranean country’s cannabis laws allowing the cultivation, sale and export of high percentage THC medical products. In May…
New York State Senator Jeremy Cooney presented a cannabis cultivation bill on July 20, which would enable farmers to start growing and selling cannabis prior to the official launch…
After a rash of states banned hemp-derived delta-8 THC when the unregulated products took regulators by surprise, Michigan is the first to change the law to…
HOMEGROWN medical cannabis is now available to German patients for the first time. Aphria RX– a wholly-owned subsidiary of Canadian pharmaceutical and cannabis company Tilray –…